Epstein-Barr virus: Biology and clinical disease
B Damania, SC Kenney, N Raab-Traub - Cell, 2022 - cell.com
Epstein-Barr virus (EBV) is a ubiquitous, oncogenic virus that is associated with a number of
different human malignancies as well as autoimmune disorders. The expression of EBV viral …
different human malignancies as well as autoimmune disorders. The expression of EBV viral …
[HTML][HTML] Epstein–Barr virus: diseases linked to infection and transformation
Epstein–Barr virus (EBV) was first discovered in 1964, and was the first known human tumor
virus now shown to be associated with a vast number of human diseases. Numerous studies …
virus now shown to be associated with a vast number of human diseases. Numerous studies …
EBV and apoptosis: the viral master regulator of cell fate?
L Fitzsimmons, GL Kelly - Viruses, 2017 - mdpi.com
Epstein–Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
(BL), and is now known to be a contributory factor in 1–2% of all cancers, for which there are …
[HTML][HTML] EBV infection and its regulated metabolic reprogramming in nasopharyngeal tumorigenesis
T Yang, C You, S Meng, Z Lai, W Ai… - Frontiers in Cellular and …, 2022 - frontiersin.org
Viral oncogenes may drive cellular metabolic reprogramming to modulate the normal
epithelia cells malignant transformation. Understanding the viral oncogenes-mediated …
epithelia cells malignant transformation. Understanding the viral oncogenes-mediated …
EBV infection and glucose metabolism in nasopharyngeal carcinoma
To establish persistent infection in cells, viruses evolve strategies to alter host cellular
pathways to regulate cell proliferation and energy metabolism which support viral infection …
pathways to regulate cell proliferation and energy metabolism which support viral infection …
Nasopharyngeal carcinoma: The role of the EGFR in epstein–barr virus infection
X Peng, Y Zhou, Y Tao, S Liu - Pathogens, 2021 - mdpi.com
Epstein–Barr virus (EBV), a type 4 γ herpes virus, is recognized as a causative agent in
nasopharyngeal carcinoma (NPC). Incidence of EBV-positive NPC have grown in recent …
nasopharyngeal carcinoma (NPC). Incidence of EBV-positive NPC have grown in recent …
Sputum cell IL-1 receptor expression level is a marker of airway neutrophilia and airflow obstruction in asthmatic patients
Background Various clinical, biologic, or physiologic markers of asthma have been used to
identify patient clusters and potential targets for therapy. However, these identifiers …
identify patient clusters and potential targets for therapy. However, these identifiers …
SSTR2 in Nasopharyngeal carcinoma: relationship with latent EBV infection and potential as a therapeutic target
O Emanuel, J Liu, VH Schartinger, WL Nei, YY Chan… - Cancers, 2021 - mdpi.com
Simple Summary Nasopharyngeal cancer (NPC) is a malignant epithelial tumor endemic to
parts of Asia and associated with infection by the Epstein–Barr virus (EBV) in these regions …
parts of Asia and associated with infection by the Epstein–Barr virus (EBV) in these regions …
Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation
ABSTRACT The Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1)
mimics CD40 signaling and is expressed by multiple malignancies. Two LMP1 C-terminal …
mimics CD40 signaling and is expressed by multiple malignancies. Two LMP1 C-terminal …
Cytopathic BVDV-1 strain induces immune marker production in bovine cells through the NF-κB signaling pathway
F Fredericksen, G Carrasco, M Villalba… - Molecular immunology, 2015 - Elsevier
The bovine viral diarrhea virus (BVDV-1) is a pathogen responsible for high economic
losses in the cattle industry worldwide. This virus has the capacity to modulate the immune …
losses in the cattle industry worldwide. This virus has the capacity to modulate the immune …